Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine for IONM in Thyroid Surgery
NCT04873531Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of neostigmine (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Time to recovery of cricothyroid muscle twitching. Started May 2021; status: completed.
02
Drugs
neostigmine
Beyond the preview
Go deeper on NCT04873531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873531.